{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:01:57Z","timestamp":1791896517716,"version":"4.3.4"},"reference-count":166,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,8,15]]},"abstract":"<jats:p>The JAK (Janus kinase) family members serve essential roles as the intracellular signalling effectors of cytokine receptors. This family, comprising JAK1, JAK2, JAK3 and TYK2 (tyrosine kinase 2), was first described more than 20\u00a0years ago, but the complexities underlying their activation, regulation and pleiotropic signalling functions are still being explored. Here, we review the current knowledge of their physiological functions and the causative role of activating and inactivating JAK mutations in human diseases, including haemopoietic malignancies, immunodeficiency and inflammatory diseases. At the molecular level, recent studies have greatly advanced our knowledge of the structures and organization of the component FERM (4.1\/ezrin\/radixin\/moesin)-SH2 (Src homology 2), pseudokinase and kinase domains within the JAKs, the mechanism of JAK activation and, in particular, the role of the pseudokinase domain as a suppressor of the adjacent tyrosine kinase domain's catalytic activity. We also review recent advances in our understanding of the mechanisms of negative regulation exerted by the SH2 domain-containing proteins, SOCS (suppressors of cytokine signalling) proteins and LNK. These recent studies highlight the diversity of regulatory mechanisms utilized by the JAK family to maintain signalling fidelity, and suggest alternative therapeutic strategies to complement existing ATP-competitive kinase inhibitors.<\/jats:p>","DOI":"10.1042\/bj20140712","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T09:27:34Z","timestamp":1406194054000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":318,"title":["The molecular regulation of Janus kinase (JAK) activation"],"prefix":"10.1042","volume":"462","author":[{"given":"Jeffrey\u00a0J.","family":"Babon","sequence":"first","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia"},{"name":"Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle\u00a0S.","family":"Lucet","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia"},{"name":"Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James\u00a0M.","family":"Murphy","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia"},{"name":"Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicos\u00a0A.","family":"Nicola","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia"},{"name":"Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila\u00a0N.","family":"Varghese","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia"},{"name":"Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"2021112216020054200_B1","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1073\/pnas.86.5.1603","article-title":"Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction","volume":"86","author":"Wilks","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B2","first-page":"2057","article-title":"Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase","volume":"11","author":"Wilks","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B3","first-page":"1329","article-title":"Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes","volume":"5","author":"Firmbach-Kraft","year":"1990","journal-title":"Oncogene"},{"key":"2021112216020054200_B4","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1073\/pnas.91.14.6374","article-title":"Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes","volume":"91","author":"Kawamura","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B5","first-page":"2415","article-title":"JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells","volume":"9","author":"Rane","year":"1994","journal-title":"Oncogene"},{"key":"2021112216020054200_B6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0092-8674(92)90105-L","article-title":"A protein tyrosine kinase in the interferon \u03b1\/\u03b2 signaling pathway","volume":"70","author":"Velazquez","year":"1992","journal-title":"Cell"},{"key":"2021112216020054200_B7","doi-asserted-by":"publisher","first-page":"34133","DOI":"10.1074\/jbc.M304531200","article-title":"STATs dimerize in the absence of phosphorylation","volume":"278","author":"Braunstein","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/BJ20030708","article-title":"Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells","volume":"377","author":"Kretzschmar","year":"2004","journal-title":"Biochem. J."},{"key":"2021112216020054200_B9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1242\/jcs.072520","article-title":"The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3","volume":"124","author":"Vogt","year":"2011","journal-title":"J. Cell Sci."},{"key":"2021112216020054200_B10","doi-asserted-by":"publisher","first-page":"7836","DOI":"10.1073\/pnas.89.16.7836","article-title":"Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha","volume":"89","author":"Schindler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.1496401","article-title":"Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor","volume":"257","author":"Schindler","year":"1992","journal-title":"Science"},{"key":"2021112216020054200_B12","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1126\/science.1281555","article-title":"Activation of transcription by IFN-\u03b3: tyrosine phosphorylation of a 91-kD DNA binding protein","volume":"258","author":"Shuai","year":"1992","journal-title":"Science"},{"key":"2021112216020054200_B13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1\u03b1 from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"key":"2021112216020054200_B14","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/endo.137.9.8756581","article-title":"Constitutive nuclear localization of Janus kinases 1 and 2","volume":"137","author":"Lobie","year":"1996","journal-title":"Endocrinology"},{"key":"2021112216020054200_B15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/08977194.2011.614949","article-title":"JAKs go nuclear: emerging role of nuclear JAK1 and JAK2\u00a0in gene expression and cell growth","volume":"29","author":"Zouein","year":"2011","journal-title":"Growth Factors"},{"key":"2021112216020054200_B16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/366166a0","article-title":"Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway","volume":"366","author":"Watling","year":"1993","journal-title":"Nature"},{"key":"2021112216020054200_B17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/366129a0","article-title":"The protein tyrosine kinase JAK1 complements defects in interferon-\u03b1\/\u03b2 and -\u03b3 signal transduction","volume":"366","author":"Muller","year":"1993","journal-title":"Nature"},{"key":"2021112216020054200_B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"2021112216020054200_B19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"2021112216020054200_B20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"2021112216020054200_B21","doi-asserted-by":"publisher","first-page":"e59675","DOI":"10.1371\/journal.pone.0059675","article-title":"Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans","volume":"8","author":"Park","year":"2013","journal-title":"PloS ONE"},{"key":"2021112216020054200_B22","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.3324\/haematol.2013.100016","article-title":"Selective deletion of Jak2\u00a0in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia","volume":"99","author":"Grisouard","year":"2014","journal-title":"Haematologica"},{"key":"2021112216020054200_B23","article-title":"Critical role of Jak2\u00a0in the maintenance and function of adult hematopoietic stem cells","volume-title":"Stem Cells","author":"Akada","year":"2014"},{"key":"2021112216020054200_B24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1084\/jem.181.4.1425","article-title":"Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7","volume":"181","author":"Musso","year":"1995","journal-title":"J. Exp. Med."},{"key":"2021112216020054200_B25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.270.5237.800","article-title":"Defective lymphoid development in mice lacking Jak3","volume":"270","author":"Nosaka","year":"1995","journal-title":"Science"},{"key":"2021112216020054200_B26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1126\/science.270.5237.794","article-title":"Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3","volume":"270","author":"Thomis","year":"1995","journal-title":"Science"},{"key":"2021112216020054200_B27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","article-title":"Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain","volume":"2","author":"Cao","year":"1995","journal-title":"Immunity"},{"key":"2021112216020054200_B28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1073\/pnas.92.2.377","article-title":"Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor \u03b3 chain","volume":"92","author":"DiSanto","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","article-title":"Interleukin-2 receptor \u03b3 chain mutation results in X-linked severe combined immunodeficiency in humans","volume":"73","author":"Noguchi","year":"1993","journal-title":"Cell"},{"key":"2021112216020054200_B30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1074-7613(00)00054-6","article-title":"Partial impairment of cytokine responses in Tyk2-deficient mice","volume":"13","author":"Karaghiosoff","year":"2000","journal-title":"Immunity"},{"key":"2021112216020054200_B31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"2021112216020054200_B32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jpeds.2012.01.056","article-title":"A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome","volume":"160","author":"Kilic","year":"2012","journal-title":"J. Pediatr."},{"key":"2021112216020054200_B33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20072182","article-title":"Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia","volume":"205","author":"Flex","year":"2008","journal-title":"J. Exp. Med."},{"key":"2021112216020054200_B34","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-07-4839","article-title":"Somatic mutations of JAK1 and JAK3\u00a0in acute leukemias and solid cancers","volume":"14","author":"Jeong","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2021112216020054200_B35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","article-title":"Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation","volume":"25","author":"Pilati","year":"2014","journal-title":"Cancer Cell"},{"key":"2021112216020054200_B36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2\u00a0in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"2021112216020054200_B37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"2021112216020054200_B38","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2\u00a0in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2021112216020054200_B39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2\u00a0in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"2021112216020054200_B40","doi-asserted-by":"publisher","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.leu.2404060","article-title":"Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia","volume":"20","author":"Kratz","year":"2006","journal-title":"Leukemia"},{"key":"2021112216020054200_B42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"2021112216020054200_B43","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/sj.onc.1209163","article-title":"The JAK2 V617F mutation in de novo acute myelogenous leukemias","volume":"25","author":"Lee","year":"2006","journal-title":"Oncogene"},{"key":"2021112216020054200_B44","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/sj.leu.2404419","article-title":"Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera","volume":"20","author":"Grunebach","year":"2006","journal-title":"Leukemia"},{"key":"2021112216020054200_B45","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/sj.leu.2404325","article-title":"Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E","volume":"20","author":"Schnittger","year":"2006","journal-title":"Leukemia"},{"key":"2021112216020054200_B46","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","article-title":"Mutations of JAK2\u00a0in acute lymphoblastic leukaemias associated with Down's syndrome","volume":"372","author":"Bercovich","year":"2008","journal-title":"Lancet"},{"key":"2021112216020054200_B47","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2353\/jmoldx.2009.080114","article-title":"Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias","volume":"11","author":"Ma","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"2021112216020054200_B49","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1182\/blood-2010-11-316810","article-title":"Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations","volume":"117","author":"Passamonti","year":"2011","journal-title":"Blood"},{"key":"2021112216020054200_B50","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.hoc.2012.07.003","article-title":"Genotype\u2013phenotype interactions in the myeloproliferative neoplasms","volume":"26","author":"Godfrey","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"2021112216020054200_B51","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL\u2013JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"2021112216020054200_B52","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"2021112216020054200_B53","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1038\/sj.onc.1208850","article-title":"The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1\u2013JAK2 fusion gene","volume":"24","author":"Bousquet","year":"2005","journal-title":"Oncogene"},{"key":"2021112216020054200_B54","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","article-title":"The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2","volume":"65","author":"Reiter","year":"2005","journal-title":"Cancer Res."},{"key":"2021112216020054200_B55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/gcc.20235","article-title":"A BCR\u2013JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia","volume":"44","author":"Griesinger","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"2021112216020054200_B56","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.molimm.2004.04.014","article-title":"Jak3 and the pathogenesis of severe combined immunodeficiency","volume":"41","author":"O\u2019Shea","year":"2004","journal-title":"Mol. Immunol."},{"key":"2021112216020054200_B57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ccr.2006.06.002","article-title":"Activating alleles of JAK3\u00a0in acute megakaryoblastic leukemia","volume":"10","author":"Walters","year":"2006","journal-title":"Cancer Cell"},{"key":"2021112216020054200_B58","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2021112216020054200_B59","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2021112216020054200_B60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10067-013-2452-7","article-title":"Tofacitinib for acute rheumatoid arthritis patients who have had an inadequate response to disease-modifying antirheumatic drug (DMARD): a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"2021112216020054200_B61","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nsmb.2807","article-title":"Structural basis of recognition of interferon-alpha receptor by tyrosine kinase 2","volume":"21","author":"Wallweber","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021112216020054200_B62","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1128\/MCB.20.10.3387-3395.2000","article-title":"Regulation of the Jak2 tyrosine kinase by its pseudokinase domain","volume":"20","author":"Saharinen","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B63","doi-asserted-by":"publisher","first-page":"47954","DOI":"10.1074\/jbc.M205156200","article-title":"The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction","volume":"277","author":"Saharinen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B64","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nsmb.2099","article-title":"The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling","volume":"18","author":"Ungureanu","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021112216020054200_B65","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/MCB.17.5.2497","article-title":"Activation of Jak2 catalytic activity requires phosphorylation of Y1007\u00a0in the kinase activation loop","volume":"17","author":"Feng","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B66","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1021\/bi036109b","article-title":"Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state","volume":"43","author":"Chatti","year":"2004","journal-title":"Biochemistry"},{"key":"2021112216020054200_B67","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/nsmb.2673","article-title":"Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases","volume":"20","author":"Toms","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021112216020054200_B68","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nsmb.2348","article-title":"Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F","volume":"19","author":"Bandaranayake","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021112216020054200_B69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20131174","article-title":"A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties","volume":"457","author":"Murphy","year":"2014","journal-title":"Biochem. J."},{"key":"2021112216020054200_B70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"2021112216020054200_B71","doi-asserted-by":"publisher","first-page":"e11157","DOI":"10.1371\/journal.pone.0011157","article-title":"JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors","volume":"5","author":"Dusa","year":"2010","journal-title":"PloS ONE"},{"key":"2021112216020054200_B72","doi-asserted-by":"publisher","first-page":"26988","DOI":"10.1074\/jbc.M109.011387","article-title":"A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation","volume":"284","author":"Zhao","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B73","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1074\/jbc.M707125200","article-title":"Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F","volume":"283","author":"Lu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B74","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1182\/blood-2007-07-102186","article-title":"The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes","volume":"111","author":"Wernig","year":"2008","journal-title":"Blood"},{"key":"2021112216020054200_B75","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1182\/blood-2009-07-236133","article-title":"Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice","volume":"116","author":"Gorantla","year":"2010","journal-title":"Blood"},{"key":"2021112216020054200_B76","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1073\/pnas.1401180111","article-title":"Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition","volume":"111","author":"Lupardus","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/BJ20131516","article-title":"Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses","volume":"458","author":"Varghese","year":"2014","journal-title":"Biochem. J."},{"key":"2021112216020054200_B78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.str.2010.10.010","article-title":"Structural snapshots of full-length Jak1, a transmembrane gp130\/IL-6\/IL-6R\u03b1 cytokine receptor complex, and the receptor\u2013Jak1 holocomplex","volume":"19","author":"Lupardus","year":"2011","journal-title":"Structure"},{"key":"2021112216020054200_B79","doi-asserted-by":"publisher","first-page":"1249783","DOI":"10.1126\/science.1249783","article-title":"Mechanism of activation of protein kinase JAK2 by the growth hormone receptor","volume":"344","author":"Brooks","year":"2014","journal-title":"Science"},{"key":"2021112216020054200_B80","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/1541-7786.MCR-12-0555","article-title":"On the regulation and activation of JAK2: a novel hypothetical model","volume":"11","author":"Lee","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"2021112216020054200_B81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nature11303","article-title":"Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy","volume":"489","author":"Koppikar","year":"2012","journal-title":"Nature"},{"key":"2021112216020054200_B82","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nsmb.2807","article-title":"Structural basis of recognition of interferon-\u03b1 receptor by tyrosine kinase 2","volume":"21","author":"Wallweber","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021112216020054200_B83","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0167-7799(97)01060-3","article-title":"Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency","volume":"15","author":"Shultz","year":"1997","journal-title":"Trends Biotechnol."},{"key":"2021112216020054200_B84","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/MCB.15.12.7050","article-title":"Differential regulation of the \u03b1\/\u03b2 interferon-stimulated Jak\/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1","volume":"15","author":"David","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B85","doi-asserted-by":"publisher","first-page":"18179","DOI":"10.1074\/jbc.270.31.18179","article-title":"Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase","volume":"270","author":"Yetter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B86","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1128\/MCB.16.12.6985","article-title":"Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1","volume":"16","author":"Jiao","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B87","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.1074\/jbc.272.22.14470","article-title":"SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates","volume":"272","author":"Bone","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B88","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1182\/blood.V87.11.4495.bloodjournal87114495","article-title":"Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis","volume":"87","author":"Tauchi","year":"1996","journal-title":"Blood"},{"key":"2021112216020054200_B89","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jsb.2012.12.009","article-title":"Structure-guided studies of the SHP-1\/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition","volume":"181","author":"Alicea-Velazquez","year":"2013","journal-title":"J. Struct. Biol."},{"key":"2021112216020054200_B90","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","article-title":"SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"2021112216020054200_B91","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/sj.leu.2403216","article-title":"SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak\/STAT pathway","volume":"18","author":"Chim","year":"2004","journal-title":"Leukemia"},{"key":"2021112216020054200_B92","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1074\/jbc.272.2.1032","article-title":"Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases","volume":"272","author":"Yin","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B93","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/MCB.19.3.2416","article-title":"Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak\/STAT pathway","volume":"19","author":"You","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B94","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2006-07-028829","article-title":"PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase","volume":"109","author":"Chan","year":"2007","journal-title":"Blood"},{"key":"2021112216020054200_B95","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"key":"2021112216020054200_B96","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1534-5807(02)00148-X","article-title":"PTP1B regulates leptin signal transduction in\u00a0vivo","volume":"2","author":"Zabolotny","year":"2002","journal-title":"Dev. Cell"},{"key":"2021112216020054200_B97","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1677\/jme.1.01694","article-title":"Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling","volume":"34","author":"Lund","year":"2005","journal-title":"J. Mol. Endocrinol."},{"key":"2021112216020054200_B98","doi-asserted-by":"publisher","first-page":"47771","DOI":"10.1074\/jbc.M009472200","article-title":"TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B","volume":"276","author":"Myers","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B99","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1534-5807(02)00149-1","article-title":"Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B","volume":"2","author":"Cheng","year":"2002","journal-title":"Dev. Cell"},{"key":"2021112216020054200_B100","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.2353\/ajpath.2010.090399","article-title":"PTP1B suppresses prolactin activation of Stat5\u00a0in breast cancer cells","volume":"177","author":"Johnson","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2021112216020054200_B101","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0960-9822(02)00697-8","article-title":"The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3","volume":"12","author":"Simoncic","year":"2002","journal-title":"Curr. Biol."},{"key":"2021112216020054200_B102","doi-asserted-by":"publisher","first-page":"U530","DOI":"10.1038\/ng.587","article-title":"Deletion of the protein tyrosine phosphatase gene PTPN2\u00a0in T-cell acute lymphoblastic leukemia","volume":"42","author":"Kleppe","year":"2010","journal-title":"Nat. Genet."},{"key":"2021112216020054200_B103","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","article-title":"PTPN2 negatively regulates oncogenic JAK1\u00a0in T-cell acute lymphoblastic leukemia","volume":"117","author":"Kleppe","year":"2011","journal-title":"Blood"},{"key":"2021112216020054200_B104","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/35053086","article-title":"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling","volume":"409","author":"Irie-Sasaki","year":"2001","journal-title":"Nature"},{"key":"2021112216020054200_B105","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1182\/blood-2011-09-379958","article-title":"Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia","volume":"119","author":"Porcu","year":"2012","journal-title":"Blood"},{"key":"2021112216020054200_B106","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/43213","article-title":"A new protein containing an SH2 domain that inhibits JAK kinases","volume":"387","author":"Endo","year":"1997","journal-title":"Nature"},{"key":"2021112216020054200_B107","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"2021112216020054200_B108","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/43219","article-title":"Structure and function of a new STAT-induced STAT inhibitor","volume":"387","author":"Naka","year":"1997","journal-title":"Nature"},{"key":"2021112216020054200_B109","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1073\/pnas.95.1.114","article-title":"Twenty proteins containing a C-terminal SOCS box form five structural classes","volume":"95","author":"Hilton","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B110","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","article-title":"The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop","volume":"18","author":"Yasukawa","year":"1999","journal-title":"EMBO J."},{"key":"2021112216020054200_B111","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2443.1999.00263.x","article-title":"Cytokine-inducible SH2 protein-3 (CIS3\/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain","volume":"4","author":"Sasaki","year":"1999","journal-title":"Genes Cells"},{"key":"2021112216020054200_B112","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1111\/j.1742-4658.2005.05010.x","article-title":"Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain","volume":"272","author":"Babon","year":"2005","journal-title":"FEBS J."},{"key":"2021112216020054200_B113","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.molcel.2006.03.024","article-title":"The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability","volume":"22","author":"Babon","year":"2006","journal-title":"Mol. Cell"},{"key":"2021112216020054200_B114","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nsmb.2519","article-title":"SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition","volume":"20","author":"Kershaw","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2021112216020054200_B115","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.immuni.2011.12.015","article-title":"Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity","volume":"36","author":"Babon","year":"2012","journal-title":"Immunity"},{"key":"2021112216020054200_B116","doi-asserted-by":"publisher","first-page":"9324","DOI":"10.1073\/pnas.161271798","article-title":"Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3","volume":"98","author":"Roberts","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B117","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni938","article-title":"IL-6 induces an anti-inflammatory response in the absence of SOCS3\u00a0in macrophages","volume":"4","author":"Yasukawa","year":"2003","journal-title":"Nat. Immunol."},{"key":"2021112216020054200_B118","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1084\/jem.20052333","article-title":"Loss of SOCS3\u00a0in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-\u03b21","volume":"203","author":"Kinjyo","year":"2006","journal-title":"J. Exp. Med."},{"key":"2021112216020054200_B119","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","article-title":"Loss of SOCS3\u00a0in the liver promotes fibrosis by enhancing STAT3-mediated TGF-\u03b21 production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"key":"2021112216020054200_B120","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in\u00a0vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat. Immunol."},{"key":"2021112216020054200_B121","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1074-7613(04)00022-6","article-title":"SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis","volume":"20","author":"Croker","year":"2004","journal-title":"Immunity"},{"key":"2021112216020054200_B122","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm1071","article-title":"Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity","volume":"10","author":"Mori","year":"2004","journal-title":"Nat. Med."},{"key":"2021112216020054200_B123","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/08977194.2012.687375","article-title":"The biology and mechanism of action of suppressor of cytokine signaling 3","volume":"30","author":"Babon","year":"2012","journal-title":"Growth Factors"},{"key":"2021112216020054200_B124","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"key":"2021112216020054200_B125","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1046\/j.1365-2567.2001.01294.x","article-title":"Neutralization of interferon-\u03b3 in neonatal SOCS1\u2212\/\u2212 mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease","volume":"104","author":"Bullen","year":"2001","journal-title":"Immunology"},{"key":"2021112216020054200_B126","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood.V97.1.221","article-title":"JAB\/SOCS1\/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling","volume":"97","author":"Sporri","year":"2001","journal-title":"Blood"},{"key":"2021112216020054200_B127","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.1073\/pnas.92.25.11618","article-title":"Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase","volume":"92","author":"Huang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B128","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.molcel.2006.06.001","article-title":"The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling","volume":"22","author":"Liu","year":"2006","journal-title":"Mol. Cell"},{"key":"2021112216020054200_B129","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/MCB.00570-06","article-title":"Binding of SH2-B family members within a potential negative regulatory region maintains JAK2\u00a0in an active state","volume":"26","author":"Kurzer","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B130","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1074\/jbc.M109165200","article-title":"SH2-B family members differentially regulate JAK family tyrosine kinases","volume":"277","author":"O\u2019Brien","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112216020054200_B131","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1074-7613(00)00060-1","article-title":"Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins","volume":"13","author":"Takaki","year":"2000","journal-title":"Immunity"},{"key":"2021112216020054200_B132","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1084\/jem.20011883","article-title":"Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice","volume":"195","author":"Velazquez","year":"2002","journal-title":"J. Exp. Med."},{"key":"2021112216020054200_B133","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.devcel.2005.03.019","article-title":"Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice","volume":"8","author":"Ema","year":"2005","journal-title":"Dev. Cell"},{"key":"2021112216020054200_B134","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1182\/blood-2004-10-4093","article-title":"Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways","volume":"105","author":"Tong","year":"2005","journal-title":"Blood"},{"key":"2021112216020054200_B135","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1101\/gad.385606","article-title":"Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK","volume":"20","author":"Buza-Vidas","year":"2006","journal-title":"Genes Dev."},{"key":"2021112216020054200_B136","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.0606238104","article-title":"Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction","volume":"104","author":"Seita","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B137","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1182\/blood-2009-12-256768","article-title":"Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms","volume":"116","author":"Baran-Marszak","year":"2010","journal-title":"Blood"},{"key":"2021112216020054200_B138","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20040762","article-title":"Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis","volume":"200","author":"Tong","year":"2004","journal-title":"J. Exp. Med."},{"key":"2021112216020054200_B139","first-page":"2832","article-title":"Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2","volume":"118","author":"Bersenev","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2021112216020054200_B140","doi-asserted-by":"publisher","first-page":"20599","DOI":"10.1073\/pnas.1319665110","article-title":"Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling","volume":"110","author":"Louria-Hayon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216020054200_B141","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1182\/blood-2010-02-270108","article-title":"Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms","volume":"116","author":"Oh","year":"2010","journal-title":"Blood"},{"key":"2021112216020054200_B142","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"2021112216020054200_B143","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood-2012-04-422691","article-title":"Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project","volume":"121","author":"Loh","year":"2013","journal-title":"Blood"},{"key":"2021112216020054200_B144","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2004.10.071","article-title":"Determination of the transphosphorylation sites of Jak2 kinase","volume":"325","author":"Matsuda","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112216020054200_B145","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.cellsig.2006.08.010","article-title":"The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type\u00a0AT1 receptor","volume":"19","author":"Godeny","year":"2007","journal-title":"Cell. Signal."},{"key":"2021112216020054200_B146","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1128\/MCB.24.11.4968-4978.2004","article-title":"Tyrosine phosphorylation of Jak2\u00a0in the JH2 domain inhibits cytokine signaling","volume":"24","author":"Feener","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B147","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/MCB.24.11.4955-4967.2004","article-title":"Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity","volume":"24","author":"Argetsinger","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B148","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1128\/MCB.00278-09","article-title":"Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling","volume":"29","author":"Robertson","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B149","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"2021112216020054200_B150","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1128\/MCB.24.10.4557-4570.2004","article-title":"Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B\u03b2","volume":"24","author":"Kurzer","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B151","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1128\/MCB.01589-05","article-title":"Phosphorylation of Jak2 on Ser523 inhibits Jak2-dependent leptin receptor signaling","volume":"26","author":"Ishida-Takahashi","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B152","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1128\/MCB.01591-05","article-title":"Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor","volume":"26","author":"Mazurkiewicz-Munoz","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B153","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1042\/BJ20121375","article-title":"SUMOylation is a regulator of the translocation of Jak2 between nucleus and cytosol","volume":"453","author":"Sedek","year":"2013","journal-title":"Biochem. J."},{"key":"2021112216020054200_B154","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1038\/sj.emboj.7601365","article-title":"Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2","volume":"25","author":"Funakoshi-Tago","year":"2006","journal-title":"EMBO J."},{"key":"2021112216020054200_B155","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.cellsig.2008.07.008","article-title":"Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway","volume":"20","author":"Funakoshi-Tago","year":"2008","journal-title":"Cell. Signal."},{"key":"2021112216020054200_B156","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1210\/me.2009-0355","article-title":"Tyrosines 868, 966, and 972\u00a0in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity","volume":"24","author":"Argetsinger","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"2021112216020054200_B157","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1182\/blood-2005-06-2413","article-title":"The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor","volume":"107","author":"Lucet","year":"2006","journal-title":"Blood"},{"key":"2021112216020054200_B158","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/gene.20063","article-title":"Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice","volume":"40","author":"Krempler","year":"2004","journal-title":"Genesis"},{"key":"2021112216020054200_B159","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1128\/MCB.24.12.5510-5520.2004","article-title":"Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice","volume":"24","author":"Wagner","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021112216020054200_B160","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/1074-7613(95)90066-7","article-title":"Developmental defects of lymphoid cells in Jak3 kinase-deficient mice","volume":"3","author":"Park","year":"1995","journal-title":"Immunity"},{"key":"2021112216020054200_B161","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"2021112216020054200_B162","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3\u00a0in a patient with SCID: essential role of Jak3\u00a0in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"2021112216020054200_B163","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S1074-7613(00)00055-8","article-title":"Tyk2 plays a restricted role in IFN\u03b1 signaling, although it is required for IL-12-mediated T cell function","volume":"13","author":"Shimoda","year":"2000","journal-title":"Immunity"},{"key":"2021112216020054200_B164","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ni910","article-title":"Central role for type\u00a0I interferons and Tyk2\u00a0in lipopolysaccharide-induced endotoxin shock","volume":"4","author":"Karaghiosoff","year":"2003","journal-title":"Nat. Immunol."},{"key":"2021112216020054200_B165","doi-asserted-by":"publisher","first-page":"11594","DOI":"10.1073\/pnas.1930781100","article-title":"A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q\/J mice to infection and autoimmunity","volume":"100","author":"Shaw","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2021112216020054200_B166","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11248-014-9795-y","article-title":"Conditional ablation of TYK2\u00a0in immunity to viral infection and tumor surveillance","volume":"23","author":"Vielnascher","year":"2014","journal-title":"Transgenic Res."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/462\/1\/1\/681211\/bj4620001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/462\/1\/1\/681211\/bj4620001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T17:47:18Z","timestamp":1637603238000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/462\/1\/1\/46823\/The-molecular-regulation-of-Janus-kinase-JAK"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20140712","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}